This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
ZFP - Chronic Granulomatous Disease
Sangamo Biosciences, Inc.
Drug Names(s): ZFP - Chronic Granulomatous Disease
Description: ZFP Therapeutic for monogenic diseases uses Sangamo's zinc finger nuclease (ZFN) gene-editing technology to target addition of the relevant curative transgene, gp91phox, into the AAVS1 safe harbor locus of HSCs.
ZFP - Chronic Granulomatous Disease News
Pink Sheet Genentech’s Actimmune
Additional information available to subscribers only: